speb/financial-data huggingface dataset:
CRMT balance_sheet (annual, 2022-04-30) — Land And Improvements: 11749000.00
CRMT balance_sheet (annual, 2022-04-30) — Leases: 36392000.00
CRMT balance_sheet (annual, 2022-04-30) — Line Of Credit: 44670000.00
CRMT balance_sheet (annual, 2022-04-30) — Long Term Capital Lease Obligation: 61481000.00
CRMT balance_sheet (annual, 2022-04-30) — Long Term Debt: 395986000.00
CRMT balance_sheet (annual, 2022-04-30) — Long Term Debt And Capital Lease Obligation: 457467000.00
CRMT cash_flow (annual, 2022-04-30) — Long Term Debt Issuance: 731107000.00
CRMT cash_flow (annual, 2022-04-30) — Long Term Debt Payments: -511042000.00
CRMT balance_sheet (annual, 2022-04-30) — Long Term Provisions: 4761000.00
CRMT balance_sheet (annual, 2022-04-30) — Machinery Furniture Equipment: 10163000.00
CRMT balance_sheet (annual, 2022-04-30) — Minority Interest: 100000.00
CRMT cash_flow (annual, 2022-04-30) — Net Common Stock Issuance: -34405000.00
CRMT balance_sheet (annual, 2022-04-30) — Net Debt: 433740000.00
CRMT income_statement (annual, 2022-04-30) — Net Income: 95014000.00
CRMT income_statement (annual, 2022-04-30) — Net Income Common Stockholders: 94974000.00
CRMT income_statement (annual, 2022-04-30) — Net Income Continuous Operations: 95014000.00
CRMT income_statement (annual, 2022-04-30) — Net Income From Continuing And Discontinued Operation: 95014000.00
CRMT income_statement (annual, 2022-04-30) — Net Income From Continuing Operation Net Minority Interest: 95014000.00
CRMT cash_flow (annual, 2022-04-30) — Net Income From Continuing Operations: 95014000.00
CRMT income_statement (annual, 2022-04-30) — Net Income Including Noncontrolling Interests: 95014000.00
CRMT income_statement (annual, 2022-04-30) — Net Interest Income: -10919000.00
CRMT cash_flow (annual, 2022-04-30) — Net Investment Purchase And Sale: -1574000.00
CRMT cash_flow (annual, 2022-04-30) — Net Issuance Payments Of Debt: 218263000.00
CRMT cash_flow (annual, 2022-04-30) — Net Long Term Debt Issuance: 220065000.00
CRMT income_statement (annual, 2022-04-30) — Net Non Operating Interest Income Expense: -10919000.00
CRMT cash_flow (annual, 2022-04-30) — Net Other Financing Charges: -6108000.00
CRMT balance_sheet (annual, 2022-04-30) — Net PPE: 104240000.00
CRMT cash_flow (annual, 2022-04-30) — Net PPE Purchase And Sale: -15776000.00
CRMT cash_flow (annual, 2022-04-30) — Net Short Term Debt Issuance: -1802000.00
CRMT balance_sheet (annual, 2022-04-30) — Net Tangible Assets: 468211000.00
CRMT balance_sheet (annual, 2022-04-30) — Non Current Deferred Liabilities: 37837000.00
CRMT balance_sheet (annual, 2022-04-30) — Non Current Deferred Revenue: 92491000.00
CRMT balance_sheet (annual, 2022-04-30) — Non Current Deferred Taxes Liabilities: 37837000.00
CRMT income_statement (annual, 2022-04-30) — Normalized EBITDA: 137736000.00
CRMT income_statement (annual, 2022-04-30) — Normalized Income: 95129440.83
CRMT cash_flow (annual, 2022-04-30) — Operating Cash Flow: -119178000.00
CRMT cash_flow (annual, 2022-04-30) — Operating Gains Losses: 149000.00
CRMT income_statement (annual, 2022-04-30) — Operating Income: 133703000.00
CRMT income_statement (annual, 2022-04-30) — Operating Revenue: 1190535000.00
CRMT balance_sheet (annual, 2022-04-30) — Ordinary Shares Number: 6371977.00
CRMT balance_sheet (annual, 2022-04-30) — Other Current Assets: 15070000.00
CRMT balance_sheet (annual, 2022-04-30) — Other Equity Adjustments: -292225000.00
CRMT income_statement (annual, 2022-04-30) — Other Income Expense: -149000.00
CRMT cash_flow (annual, 2022-04-30) — Other Non Cash Items: 22646000.00
CRMT balance_sheet (annual, 2022-04-30) — Other Properties: 58828000.00
CRMT balance_sheet (annual, 2022-04-30) — Payables: 20055000.00
CRMT balance_sheet (annual, 2022-04-30) — Payables And Accrued Expenses: 27671000.00
CRMT balance_sheet (annual, 2022-04-30) — Preferred Stock: 400000.00
CRMT income_statement (annual, 2022-04-30) — Preferred Stock Dividends: 40000.00
CRMT balance_sheet (annual, 2022-04-30) — Preferred Stock Equity: 400000.00
CRMT balance_sheet (annual, 2022-04-30) — Prepaid Assets: 9044000.00
CRMT income_statement (annual, 2022-04-30) — Pretax Income: 122635000.00
CRMT cash_flow (annual, 2022-04-30) — Proceeds From Stock Option Exercised: -1488000.00
CRMT balance_sheet (annual, 2022-04-30) — Properties: 0.00
CRMT income_statement (annual, 2022-04-30) — Provision For Doubtful Accounts: 238054000.00
CRMT cash_flow (annual, 2022-04-30) — Provisionand Write Offof Assets: 238054000.00
CRMT cash_flow (annual, 2022-04-30) — Purchase Of Investment: -1574000.00
CRMT cash_flow (annual, 2022-04-30) — Purchase Of PPE: -15796000.00
CRMT balance_sheet (annual, 2022-04-30) — Receivables: 868874000.00
CRMT income_statement (annual, 2022-04-30) — Reconciled Cost Of Revenue: 658615000.00
CRMT income_statement (annual, 2022-04-30) — Reconciled Depreciation: 4033000.00
CRMT cash_flow (annual, 2022-04-30) — Repayment Of Debt: -511042000.00
CRMT cash_flow (annual, 2022-04-30) — Repurchase Of Capital Stock: -34698000.00
CRMT balance_sheet (annual, 2022-04-30) — Restricted Cash: 35671000.00
CRMT balance_sheet (annual, 2022-04-30) — Retained Earnings: 665410000.00
CRMT cash_flow (annual, 2022-04-30) — Sale Of PPE: 20000.00
CRMT income_statement (annual, 2022-04-30) — Selling General And Administration: 156130000.00
CRMT balance_sheet (annual, 2022-04-30) — Share Issued: 13642185.00
CRMT income_statement (annual, 2022-04-30) — Special Income Charges: -149000.00
CRMT cash_flow (annual, 2022-04-30) — Stock Based Compensation: 5496000.00
CRMT balance_sheet (annual, 2022-04-30) — Stockholders Equity: 476834000.00
CRMT balance_sheet (annual, 2022-04-30) — Tangible Book Value: 467811000.00
CRMT income_statement (annual, 2022-04-30) — Tax Effect Of Unusual Items: -33559.17
CRMT income_statement (annual, 2022-04-30) — Tax Provision: 27621000.00
CRMT income_statement (annual, 2022-04-30) — Tax Rate For Calcs: 0.23
CRMT balance_sheet (annual, 2022-04-30) — Taxes Receivable: 274000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Assets: 1154696000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Capitalization: 872820000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Debt: 502137000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Equity Gross Minority Interest: 476934000.00
CRMT income_statement (annual, 2022-04-30) — Total Expenses: 1056832000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Liabilities Net Minority Interest: 677762000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Non Current Assets: 112863000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Non Current Liabilities Net Minority Interest: 512930000.00
CRMT balance_sheet (annual, 2022-04-30) — Total Tax Payable: 0.00
CRMT income_statement (annual, 2022-04-30) — Total Unusual Items: -149000.00
CRMT income_statement (annual, 2022-04-30) — Total Unusual Items Excluding Goodwill: -149000.00
CRMT balance_sheet (annual, 2022-04-30) — Treasury Shares Number: 7270208.00
CRMT balance_sheet (annual, 2022-04-30) — Treasury Stock: 292225000.00
CRMT balance_sheet (annual, 2022-04-30) — Working Capital: 877001000.00
CRMT income_statement (annual, 2023-04-30) — +Operating Expense: 535158000.00
CRMT income_statement (annual, 2023-04-30) — +Total Revenue: 1400413000.00
CRMT balance_sheet (annual, 2023-04-30) — Accounts Payable: 27196000.00
CRMT balance_sheet (annual, 2023-04-30) — Accounts Receivable: 1062760000.00
CRMT balance_sheet (annual, 2023-04-30) — Accrued Interest Receivable: 6115000.00
CRMT balance_sheet (annual, 2023-04-30) — Accumulated Depreciation: -45078000.00
CRMT balance_sheet (annual, 2023-04-30) — Additional Paid In Capital: 109929000.00
CRMT balance_sheet (annual, 2023-04-30) — Allowance For Doubtful Accounts Receivable: -299608000.00
CRMT cash_flow (annual, 2023-04-30) — Asset Impairment Charge: 0.00
CRMT income_statement (annual, 2023-04-30) — Basic Average Shares: 6371229.00
CRMT income_statement (annual, 2023-04-30) — Basic EPS: 3.20
CRMT cash_flow (annual, 2023-04-30) — Beginning Cash Position: 42587000.00
CRMT balance_sheet (annual, 2023-04-30) — Buildings And Improvements: 20894000.00
CRMT cash_flow (annual, 2023-04-30) — Capital Expenditure: -22106000.00
CRMT balance_sheet (annual, 2023-04-30) — Capital Lease Obligations: 62300000.00
CRMT balance_sheet (annual, 2023-04-30) — Capital Stock: 537000.00
CRMT balance_sheet (annual, 2023-04-30) — Cash And Cash Equivalents: 9796000.00
CRMT balance_sheet (annual, 2023-04-30) — Cash Cash Equivalents And Short Term Investments: 9796000.00
CRMT cash_flow (annual, 2023-04-30) — Cash Dividends Paid: -40000.00
CRMT cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Financing Activities: 188746000.00
CRMT cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Investing Activities: -27571000.00
CRMT cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Operating Activities: -135728000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Account Payable: 8621000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Inventory: 133047000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Other Working Capital: 32708000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Payable: 8621000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Payables And Accrued Expense: 8621000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Prepaid Assets: -6235000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Receivables: -727862000.00
CRMT cash_flow (annual, 2023-04-30) — Change In Working Capital: -559721000.00
CRMT cash_flow (annual, 2023-04-30) — Changes In Account Receivables: -726674000.00
CRMT cash_flow (annual, 2023-04-30) — Changes In Cash: 25447000.00
CRMT balance_sheet (annual, 2023-04-30) — Common Stock: 137000.00
CRMT cash_flow (annual, 2023-04-30) — Common Stock Dividend Paid: -40000.00
CRMT balance_sheet (annual, 2023-04-30) — Common Stock Equity: 498447000.00
CRMT cash_flow (annual, 2023-04-30) — Common Stock Issuance: 286000.00
CRMT cash_flow (annual, 2023-04-30) — Common Stock Payments: -5196000.00
CRMT balance_sheet (annual, 2023-04-30) — Construction In Progress: 7176000.00
CRMT income_statement (annual, 2023-04-30) — Cost Of Revenue: 800788000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Accrued Expenses: 8172000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Assets: 1256158000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Debt: 167231000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Debt And Capital Lease Obligation: 167231000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Deferred Liabilities: 120469000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Deferred Revenue: 120469000.00
CRMT balance_sheet (annual, 2023-04-30) — Current Liabilities: 323068000.00
CRMT cash_flow (annual, 2023-04-30) — Deferred Income Tax: 8866000.00
CRMT cash_flow (annual, 2023-04-30) — Deferred Tax: 8866000.00
CRMT cash_flow (annual, 2023-04-30) — Depreciation Amortization Depletion: 5602000.00
CRMT income_statement (annual, 2023-04-30) — Depreciation Amortization Depletion Income Statement: 5602000.00
CRMT cash_flow (annual, 2023-04-30) — Depreciation And Amortization: 5602000.00
CRMT income_statement (annual, 2023-04-30) — Depreciation And Amortization In Income Statement: 5602000.00
CRMT income_statement (annual, 2023-04-30) — Diluted Average Shares: 6566896.00
CRMT income_statement (annual, 2023-04-30) — Diluted EPS: 3.11
CRMT income_statement (annual, 2023-04-30) — Diluted NI Availto Com Stockholders: 20392000.00
CRMT income_statement (annual, 2023-04-30) — EBIT: 64106000.00
CRMT income_statement (annual, 2023-04-30) — EBITDA: 69708000.00
CRMT balance_sheet (annual, 2023-04-30) — Employee Benefits: 11197000.00
CRMT cash_flow (annual, 2023-04-30) — End Cash Position: 68034000.00
CRMT cash_flow (annual, 2023-04-30) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (annual, 2023-04-30) — Financing Cash Flow: 188746000.00
CRMT cash_flow (annual, 2023-04-30) — Free Cash Flow: -157834000.00
CRMT cash_flow (annual, 2023-04-30) — Gain Loss On Sale Of PPE: 361000.00
CRMT income_statement (annual, 2023-04-30) — Gain On Sale Of Ppe: -361000.00
CRMT balance_sheet (annual, 2023-04-30) — Gains Losses Not Affecting Retained Earnings: -297421000.00
CRMT balance_sheet (annual, 2023-04-30) — Goodwill: 11716000.00
CRMT balance_sheet (annual, 2023-04-30) — Goodwill And Other Intangible Assets: 11716000.00
CRMT balance_sheet (annual, 2023-04-30) — Gross Accounts Receivable: 1362368000.00
CRMT balance_sheet (annual, 2023-04-30) — Gross PPE: 165902000.00
CRMT income_statement (annual, 2023-04-30) — Gross Profit: 599625000.00
CRMT cash_flow (annual, 2023-04-30) — Income Tax Paid Supplemental Data: 5480000.00
CRMT income_statement (annual, 2023-04-30) — Interest Expense: 38312000.00
CRMT income_statement (annual, 2023-04-30) — Interest Expense Non Operating: 38312000.00
CRMT cash_flow (annual, 2023-04-30) — Interest Paid Supplemental Data: 36605000.00
CRMT balance_sheet (annual, 2023-04-30) — Inventory: 109290000.00
CRMT balance_sheet (annual, 2023-04-30) — Invested Capital: 1137045000.00
CRMT cash_flow (annual, 2023-04-30) — Investing Cash Flow: -27571000.00
CRMT cash_flow (annual, 2023-04-30) — Issuance Of Capital Stock: 286000.00
CRMT cash_flow (annual, 2023-04-30) — Issuance Of Debt: 924707000.00
CRMT balance_sheet (annual, 2023-04-30) — Land And Improvements: 12386000.00
CRMT balance_sheet (annual, 2023-04-30) — Leases: 47315000.00
CRMT balance_sheet (annual, 2023-04-30) — Line Of Credit: 167231000.00
CRMT balance_sheet (annual, 2023-04-30) — Loans Receivable: 700000.00
CRMT balance_sheet (annual, 2023-04-30) — Long Term Capital Lease Obligation: 62300000.00
CRMT balance_sheet (annual, 2023-04-30) — Long Term Debt: 471367000.00
CRMT balance_sheet (annual, 2023-04-30) — Long Term Debt And Capital Lease Obligation: 533667000.00
CRMT cash_flow (annual, 2023-04-30) — Long Term Debt Issuance: 924707000.00
CRMT cash_flow (annual, 2023-04-30) — Long Term Debt Payments: -729964000.00
CRMT balance_sheet (annual, 2023-04-30) — Long Term Provisions: 5694000.00
CRMT balance_sheet (annual, 2023-04-30) — Machinery Furniture Equipment: 18989000.00
CRMT balance_sheet (annual, 2023-04-30) — Minority Interest: 100000.00
CRMT cash_flow (annual, 2023-04-30) — Net Common Stock Issuance: -4910000.00
CRMT balance_sheet (annual, 2023-04-30) — Net Debt: 628802000.00
CRMT income_statement (annual, 2023-04-30) — Net Income: 20432000.00
CRMT income_statement (annual, 2023-04-30) — Net Income Common Stockholders: 20392000.00
CRMT income_statement (annual, 2023-04-30) — Net Income Continuous Operations: 20432000.00
CRMT income_statement (annual, 2023-04-30) — Net Income From Continuing And Discontinued Operation: 20432000.00
CRMT income_statement (annual, 2023-04-30) — Net Income From Continuing Operation Net Minority Interest: 20432000.00
CRMT cash_flow (annual, 2023-04-30) — Net Income From Continuing Operations: 20432000.00
CRMT income_statement (annual, 2023-04-30) — Net Income Including Noncontrolling Interests: 20432000.00
CRMT income_statement (annual, 2023-04-30) — Net Interest Income: -38312000.00
CRMT cash_flow (annual, 2023-04-30) — Net Investment Purchase And Sale: -5549000.00
CRMT cash_flow (annual, 2023-04-30) — Net Issuance Payments Of Debt: 194743000.00
CRMT cash_flow (annual, 2023-04-30) — Net Long Term Debt Issuance: 194743000.00
CRMT income_statement (annual, 2023-04-30) — Net Non Operating Interest Income Expense: -38312000.00
CRMT cash_flow (annual, 2023-04-30) — Net Other Financing Charges: -2263000.00
CRMT balance_sheet (annual, 2023-04-30) — Net PPE: 120824000.00
CRMT cash_flow (annual, 2023-04-30) — Net PPE Purchase And Sale: -22022000.00
CRMT cash_flow (annual, 2023-04-30) — Net Short Term Debt Issuance: 0.00
CRMT balance_sheet (annual, 2023-04-30) — Net Tangible Assets: 487131000.00
CRMT balance_sheet (annual, 2023-04-30) — Non Current Deferred Liabilities: 47858000.00
CRMT balance_sheet (annual, 2023-04-30) — Non Current Deferred Revenue: 120469000.00
CRMT balance_sheet (annual, 2023-04-30) — Non Current Deferred Taxes Liabilities: 47858000.00
CRMT income_statement (annual, 2023-04-30) — Normalized EBITDA: 70069000.00
CRMT income_statement (annual, 2023-04-30) — Normalized Income: 20717956.11
CRMT cash_flow (annual, 2023-04-30) — Operating Cash Flow: -135728000.00
CRMT cash_flow (annual, 2023-04-30) — Operating Gains Losses: 361000.00
CRMT income_statement (annual, 2023-04-30) — Operating Income: 64467000.00
CRMT income_statement (annual, 2023-04-30) — Operating Revenue: 1400413000.00
CRMT balance_sheet (annual, 2023-04-30) — Ordinary Shares Number: 6373404.00
CRMT balance_sheet (annual, 2023-04-30) — Other Current Assets: 21429000.00
CRMT balance_sheet (annual, 2023-04-30) — Other Equity Adjustments: -297421000.00
CRMT income_statement (annual, 2023-04-30) — Other Income Expense: -361000.00
CRMT cash_flow (annual, 2023-04-30) — Other Non Cash Items: 30558000.00
CRMT balance_sheet (annual, 2023-04-30) — Other Non Current Assets: 26039000.00
CRMT balance_sheet (annual, 2023-04-30) — Other Properties: 59142000.00
CRMT balance_sheet (annual, 2023-04-30) — Payables: 27196000.00
CRMT balance_sheet (annual, 2023-04-30) — Payables And Accrued Expenses: 35368000.00
CRMT balance_sheet (annual, 2023-04-30) — Preferred Stock: 400000.00
CRMT income_statement (annual, 2023-04-30) — Preferred Stock Dividends: 40000.00
CRMT balance_sheet (annual, 2023-04-30) — Preferred Stock Equity: 400000.00
CRMT income_statement (annual, 2023-04-30) — Pretax Income: 25794000.00
CRMT cash_flow (annual, 2023-04-30) — Proceeds From Stock Option Exercised: 1216000.00
CRMT balance_sheet (annual, 2023-04-30) — Properties: 0.00
CRMT income_statement (annual, 2023-04-30) — Provision For Doubtful Accounts: 352860000.00
CRMT cash_flow (annual, 2023-04-30) — Provisionand Write Offof Assets: 352860000.00
CRMT cash_flow (annual, 2023-04-30) — Purchase Of Investment: -5549000.00
CRMT cash_flow (annual, 2023-04-30) — Purchase Of PPE: -22106000.00
CRMT balance_sheet (annual, 2023-04-30) — Receivables: 1078834000.00
CRMT income_statement (annual, 2023-04-30) — Reconciled Cost Of Revenue: 800788000.00
CRMT income_statement (annual, 2023-04-30) — Reconciled Depreciation: 5602000.00
CRMT cash_flow (annual, 2023-04-30) — Repayment Of Debt: -729964000.00
CRMT cash_flow (annual, 2023-04-30) — Repurchase Of Capital Stock: -5196000.00
CRMT balance_sheet (annual, 2023-04-30) — Restricted Cash: 58238000.00
CRMT balance_sheet (annual, 2023-04-30) — Retained Earnings: 685802000.00
CRMT cash_flow (annual, 2023-04-30) — Sale Of PPE: 84000.00
CRMT income_statement (annual, 2023-04-30) — Selling General And Administration: 176696000.00
CRMT balance_sheet (annual, 2023-04-30) — Share Issued: 13701468.00
CRMT income_statement (annual, 2023-04-30) — Special Income Charges: -361000.00
CRMT cash_flow (annual, 2023-04-30) — Stock Based Compensation: 5314000.00
CRMT balance_sheet (annual, 2023-04-30) — Stockholders Equity: 498847000.00
CRMT balance_sheet (annual, 2023-04-30) — Tangible Book Value: 486731000.00
CRMT income_statement (annual, 2023-04-30) — Tax Effect Of Unusual Items: -75043.89
CRMT income_statement (annual, 2023-04-30) — Tax Provision: 5362000.00
CRMT income_statement (annual, 2023-04-30) — Tax Rate For Calcs: 0.21
CRMT balance_sheet (annual, 2023-04-30) — Taxes Receivable: 9259000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Assets: 1414737000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Capitalization: 970214000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Debt: 700898000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Equity Gross Minority Interest: 498947000.00
CRMT income_statement (annual, 2023-04-30) — Total Expenses: 1335946000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Liabilities Net Minority Interest: 915790000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Non Current Assets: 158579000.00
CRMT balance_sheet (annual, 2023-04-30) — Total Non Current Liabilities Net Minority Interest: 592722000.00
CRMT income_statement (annual, 2023-04-30) — Total Unusual Items: -361000.00
CRMT income_statement (annual, 2023-04-30) — Total Unusual Items Excluding Goodwill: -361000.00
CRMT balance_sheet (annual, 2023-04-30) — Treasury Shares Number: 7328064.00
CRMT balance_sheet (annual, 2023-04-30) — Treasury Stock: 297421000.00
CRMT balance_sheet (annual, 2023-04-30) — Working Capital: 933090000.00
CRMT income_statement (annual, 2024-04-30) — +Operating Expense: 609698000.00
CRMT income_statement (annual, 2024-04-30) — +Total Revenue: 1393894000.00
CRMT balance_sheet (annual, 2024-04-30) — Accounts Payable: 21379000.00
CRMT balance_sheet (annual, 2024-04-30) — Accounts Receivable: 1097931000.00
CRMT balance_sheet (annual, 2024-04-30) — Accrued Interest Receivable: 6907000.00
CRMT balance_sheet (annual, 2024-04-30) — Accumulated Depreciation: -49906000.00
CRMT balance_sheet (annual, 2024-04-30) — Additional Paid In Capital: 113930000.00
CRMT balance_sheet (annual, 2024-04-30) — Allowance For Doubtful Accounts Receivable: -331260000.00
CRMT cash_flow (annual, 2024-04-30) — Asset Impairment Charge: 267000.00
CRMT income_statement (annual, 2024-04-30) — Basic Average Shares: 6388537.00
CRMT income_statement (annual, 2024-04-30) — Basic EPS: -4.92
CRMT cash_flow (annual, 2024-04-30) — Beginning Cash Position: 68034000.00
CRMT balance_sheet (annual, 2024-04-30) — Buildings And Improvements: 23435000.00
CRMT cash_flow (annual, 2024-04-30) — Capital Expenditure: -6146000.00
CRMT balance_sheet (annual, 2024-04-30) — Capital Lease Obligations: 64250000.00
CRMT balance_sheet (annual, 2024-04-30) — Capital Stock: 537000.00
CRMT balance_sheet (annual, 2024-04-30) — Cash And Cash Equivalents: 5522000.00
CRMT balance_sheet (annual, 2024-04-30) — Cash Cash Equivalents And Short Term Investments: 5522000.00
CRMT cash_flow (annual, 2024-04-30) — Cash Dividends Paid: -40000.00
CRMT cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Financing Activities: 110956000.00
CRMT cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Investing Activities: -10645000.00
CRMT cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Operating Activities: -73898000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Inventory: 139186000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Other Working Capital: 6612000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Payables And Accrued Expense: -9338000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Prepaid Assets: -7386000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Receivables: -624910000.00
CRMT cash_flow (annual, 2024-04-30) — Change In Working Capital: -495836000.00
CRMT cash_flow (annual, 2024-04-30) — Changes In Account Receivables: -624118000.00
CRMT cash_flow (annual, 2024-04-30) — Changes In Cash: 26413000.00
CRMT balance_sheet (annual, 2024-04-30) — Common Stock: 137000.00
CRMT cash_flow (annual, 2024-04-30) — Common Stock Dividend Paid: -40000.00
CRMT balance_sheet (annual, 2024-04-30) — Common Stock Equity: 470650000.00
CRMT cash_flow (annual, 2024-04-30) — Common Stock Issuance: 282000.00
CRMT cash_flow (annual, 2024-04-30) — Common Stock Payments: -365000.00
CRMT balance_sheet (annual, 2024-04-30) — Construction In Progress: 2393000.00
CRMT income_statement (annual, 2024-04-30) — Cost Of Revenue: 758546000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Accrued Expenses: 9997000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Assets: 1310373000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Debt: 201642000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Debt And Capital Lease Obligation: 201642000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Deferred Liabilities: 120781000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Deferred Revenue: 120781000.00
CRMT balance_sheet (annual, 2024-04-30) — Current Liabilities: 353799000.00
CRMT cash_flow (annual, 2024-04-30) — Deferred Income Tax: -21507000.00
CRMT cash_flow (annual, 2024-04-30) — Deferred Tax: -21507000.00
CRMT cash_flow (annual, 2024-04-30) — Depreciation Amortization Depletion: 6871000.00
CRMT income_statement (annual, 2024-04-30) — Depreciation Amortization Depletion Income Statement: 6871000.00
CRMT cash_flow (annual, 2024-04-30) — Depreciation And Amortization: 6871000.00
CRMT income_statement (annual, 2024-04-30) — Depreciation And Amortization In Income Statement: 6871000.00
CRMT income_statement (annual, 2024-04-30) — Diluted Average Shares: 6388537.00
CRMT income_statement (annual, 2024-04-30) — Diluted EPS: -4.92
CRMT income_statement (annual, 2024-04-30) — Diluted NI Availto Com Stockholders: -31433000.00
CRMT income_statement (annual, 2024-04-30) — EBIT: 25213000.00
CRMT income_statement (annual, 2024-04-30) — EBITDA: 32084000.00
CRMT balance_sheet (annual, 2024-04-30) — Employee Benefits: 10774000.00
CRMT cash_flow (annual, 2024-04-30) — End Cash Position: 94447000.00
CRMT cash_flow (annual, 2024-04-30) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (annual, 2024-04-30) — Financing Cash Flow: 110956000.00
CRMT cash_flow (annual, 2024-04-30) — Free Cash Flow: -80044000.00
CRMT cash_flow (annual, 2024-04-30) — Gain Loss On Sale Of PPE: 437000.00
CRMT income_statement (annual, 2024-04-30) — Gain On Sale Of Ppe: -437000.00
CRMT balance_sheet (annual, 2024-04-30) — Goodwill: 14449000.00
CRMT balance_sheet (annual, 2024-04-30) — Goodwill And Other Intangible Assets: 14449000.00
CRMT balance_sheet (annual, 2024-04-30) — Gross Accounts Receivable: 1429191000.00
CRMT balance_sheet (annual, 2024-04-30) — Gross PPE: 171452000.00
CRMT income_statement (annual, 2024-04-30) — Gross Profit: 635348000.00
CRMT cash_flow (annual, 2024-04-30) — Income Tax Paid Supplemental Data: 6459000.00
CRMT balance_sheet (annual, 2024-04-30) — Income Tax Payable: 0.00
CRMT income_statement (annual, 2024-04-30) — Interest Expense: 65348000.00
CRMT income_statement (annual, 2024-04-30) — Interest Expense Non Operating: 65348000.00
CRMT cash_flow (annual, 2024-04-30) — Interest Paid Supplemental Data: 65647000.00
CRMT balance_sheet (annual, 2024-04-30) — Interest Payable: 2221000.00
CRMT balance_sheet (annual, 2024-04-30) — Inventory: 107470000.00
CRMT balance_sheet (annual, 2024-04-30) — Invested Capital: 1225921000.00
CRMT cash_flow (annual, 2024-04-30) — Investing Cash Flow: -10645000.00
CRMT cash_flow (annual, 2024-04-30) — Issuance Of Capital Stock: 282000.00
CRMT cash_flow (annual, 2024-04-30) — Issuance Of Debt: 1164933000.00
CRMT balance_sheet (annual, 2024-04-30) — Land And Improvements: 11998000.00
CRMT balance_sheet (annual, 2024-04-30) — Leases: 50689000.00
CRMT balance_sheet (annual, 2024-04-30) — Line Of Credit: 201642000.00
CRMT balance_sheet (annual, 2024-04-30) — Loans Receivable: 660000.00
CRMT balance_sheet (annual, 2024-04-30) — Long Term Capital Lease Obligation: 64250000.00
CRMT balance_sheet (annual, 2024-04-30) — Long Term Debt: 553629000.00
CRMT balance_sheet (annual, 2024-04-30) — Long Term Debt And Capital Lease Obligation: 617879000.00
CRMT cash_flow (annual, 2024-04-30) — Long Term Debt Issuance: 1164933000.00
CRMT cash_flow (annual, 2024-04-30) — Long Term Debt Payments: -1048325000.00
CRMT balance_sheet (annual, 2024-04-30) — Machinery Furniture Equipment: 21752000.00
CRMT balance_sheet (annual, 2024-04-30) — Minority Interest: 100000.00
CRMT cash_flow (annual, 2024-04-30) — Net Common Stock Issuance: -83000.00
CRMT balance_sheet (annual, 2024-04-30) — Net Debt: 749749000.00
CRMT income_statement (annual, 2024-04-30) — Net Income: -31393000.00
CRMT income_statement (annual, 2024-04-30) — Net Income Common Stockholders: -31433000.00
CRMT income_statement (annual, 2024-04-30) — Net Income Continuous Operations: -31393000.00
CRMT income_statement (annual, 2024-04-30) — Net Income From Continuing And Discontinued Operation: -31393000.00
CRMT income_statement (annual, 2024-04-30) — Net Income From Continuing Operation Net Minority Interest: -31393000.00
CRMT cash_flow (annual, 2024-04-30) — Net Income From Continuing Operations: -31393000.00
CRMT income_statement (annual, 2024-04-30) — Net Income Including Noncontrolling Interests: -31393000.00
CRMT income_statement (annual, 2024-04-30) — Net Interest Income: -65348000.00
CRMT cash_flow (annual, 2024-04-30) — Net Investment Purchase And Sale: -4815000.00
CRMT cash_flow (annual, 2024-04-30) — Net Issuance Payments Of Debt: 117431000.00
CRMT cash_flow (annual, 2024-04-30) — Net Long Term Debt Issuance: 116608000.00
CRMT income_statement (annual, 2024-04-30) — Net Non Operating Interest Income Expense: -65348000.00
CRMT cash_flow (annual, 2024-04-30) — Net Other Financing Charges: -5897000.00
CRMT balance_sheet (annual, 2024-04-30) — Net PPE: 121546000.00
CRMT cash_flow (annual, 2024-04-30) — Net PPE Purchase And Sale: -5830000.00
CRMT cash_flow (annual, 2024-04-30) — Net Short Term Debt Issuance: 823000.00
CRMT balance_sheet (annual, 2024-04-30) — Net Tangible Assets: 456601000.00
CRMT balance_sheet (annual, 2024-04-30) — Non Current Deferred Liabilities: 24042000.00
CRMT balance_sheet (annual, 2024-04-30) — Non Current Deferred Taxes Liabilities: 24042000.00
CRMT income_statement (annual, 2024-04-30) — Normalized EBITDA: 32521000.00
CRMT income_statement (annual, 2024-04-30) — Normalized Income: -31051185.10
CRMT cash_flow (annual, 2024-04-30) — Operating Cash Flow: -73898000.00
CRMT cash_flow (annual, 2024-04-30) — Operating Gains Losses: 437000.00
CRMT income_statement (annual, 2024-04-30) — Operating Income: 25650000.00
CRMT income_statement (annual, 2024-04-30) — Operating Revenue: 1393894000.00
CRMT balance_sheet (annual, 2024-04-30) — Ordinary Shares Number: 6394675.00
CRMT income_statement (annual, 2024-04-30) — Other Income Expense: -437000.00
CRMT cash_flow (annual, 2024-04-30) — Other Non Cash Items: 39683000.00
CRMT balance_sheet (annual, 2024-04-30) — Other Non Current Assets: 31276000.00
CRMT balance_sheet (annual, 2024-04-30) — Other Properties: 61185000.00
CRMT balance_sheet (annual, 2024-04-30) — Payables: 21379000.00
CRMT balance_sheet (annual, 2024-04-30) — Payables And Accrued Expenses: 31376000.00
CRMT balance_sheet (annual, 2024-04-30) — Preferred Stock: 400000.00
CRMT income_statement (annual, 2024-04-30) — Preferred Stock Dividends: 40000.00
CRMT balance_sheet (annual, 2024-04-30) — Preferred Stock Equity: 400000.00
CRMT income_statement (annual, 2024-04-30) — Pretax Income: -40135000.00
CRMT cash_flow (annual, 2024-04-30) — Proceeds From Stock Option Exercised: -455000.00
CRMT balance_sheet (annual, 2024-04-30) — Properties: 0.00
CRMT income_statement (annual, 2024-04-30) — Provision For Doubtful Accounts: 423406000.00
CRMT cash_flow (annual, 2024-04-30) — Provisionand Write Offof Assets: 423406000.00
CRMT cash_flow (annual, 2024-04-30) — Purchase Of Investment: -4815000.00
CRMT cash_flow (annual, 2024-04-30) — Purchase Of PPE: -6146000.00
CRMT balance_sheet (annual, 2024-04-30) — Receivables: 1108456000.00
CRMT income_statement (annual, 2024-04-30) — Reconciled Cost Of Revenue: 758546000.00
CRMT income_statement (annual, 2024-04-30) — Reconciled Depreciation: 6871000.00
CRMT cash_flow (annual, 2024-04-30) — Repayment Of Debt: -1048325000.00
CRMT cash_flow (annual, 2024-04-30) — Repurchase Of Capital Stock: -365000.00
CRMT balance_sheet (annual, 2024-04-30) — Restricted Cash: 88925000.00
CRMT balance_sheet (annual, 2024-04-30) — Retained Earnings: 654369000.00
CRMT cash_flow (annual, 2024-04-30) — Sale Of PPE: 316000.00
CRMT income_statement (annual, 2024-04-30) — Selling General And Administration: 179421000.00
CRMT balance_sheet (annual, 2024-04-30) — Share Issued: 13727013.00
CRMT income_statement (annual, 2024-04-30) — Special Income Charges: -437000.00
CRMT cash_flow (annual, 2024-04-30) — Stock Based Compensation: 4174000.00
CRMT balance_sheet (annual, 2024-04-30) — Stockholders Equity: 471050000.00
CRMT balance_sheet (annual, 2024-04-30) — Tangible Book Value: 456201000.00
CRMT income_statement (annual, 2024-04-30) — Tax Effect Of Unusual Items: -95185.10
CRMT income_statement (annual, 2024-04-30) — Tax Provision: -8742000.00
CRMT income_statement (annual, 2024-04-30) — Tax Rate For Calcs: 0.22
CRMT balance_sheet (annual, 2024-04-30) — Taxes Receivable: 2958000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Assets: 1477644000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Capitalization: 1024679000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Debt: 819521000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Equity Gross Minority Interest: 471150000.00
CRMT income_statement (annual, 2024-04-30) — Total Expenses: 1368244000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Liabilities Net Minority Interest: 1006494000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Non Current Assets: 167271000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Non Current Liabilities Net Minority Interest: 652695000.00
CRMT balance_sheet (annual, 2024-04-30) — Total Tax Payable: 0.00
CRMT income_statement (annual, 2024-04-30) — Total Unusual Items: -437000.00
CRMT income_statement (annual, 2024-04-30) — Total Unusual Items Excluding Goodwill: -437000.00
CRMT balance_sheet (annual, 2024-04-30) — Treasury Shares Number: 7332338.00
CRMT balance_sheet (annual, 2024-04-30) — Treasury Stock: 297786000.00
CRMT balance_sheet (annual, 2024-04-30) — Working Capital: 956574000.00
CRMT income_statement (annual, 2024-04-30) — Write Off: 0.00
CRMT cash_flow (quarterly, 2024-10-31) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (quarterly, 2024-10-31) — Interest Paid Supplemental Data: 18789000.00
CRMT cash_flow (quarterly, 2024-10-31) — Net Business Purchase And Sale: 0.00
CRMT cash_flow (quarterly, 2024-10-31) — Proceeds From Stock Option Exercised: 0.00
CRMT cash_flow (quarterly, 2024-10-31) — Purchase Of Business: 0.00
CRMT cash_flow (quarterly, 2024-10-31) — Short Term Debt Issuance: 161509000.00
CRMT cash_flow (quarterly, 2024-10-31) — Short Term Debt Payments: -237753000.00
CRMT income_statement (quarterly, 2025-01-31) — +Operating Expense: 135002000.00
CRMT income_statement (quarterly, 2025-01-31) — +Total Revenue: 325726000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 32747000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 1145567000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Accrued Interest Receivable: 7056000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -55380000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 194237000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Allowance For Doubtful Accounts Receivable: -333338000.00
CRMT cash_flow (quarterly, 2025-01-31) — Asset Impairment Charge: 37000.00
CRMT income_statement (quarterly, 2025-01-31) — Basic Average Shares: 8256681.00
CRMT income_statement (quarterly, 2025-01-31) — Basic EPS: 0.38
CRMT cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 129684000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Buildings And Improvements: 23488000.00
CRMT cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -751000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 67667000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Capital Stock: 556000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 8532000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 8532000.00
CRMT cash_flow (quarterly, 2025-01-31) — Cash Dividends Paid: -10000.00
CRMT cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 28201000.00
CRMT cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -751000.00
CRMT cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -30776000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Inventory: 5189000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -137000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 6018000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: -2002000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Receivables: -136913000.00
CRMT cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -127845000.00
CRMT cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: -137430000.00
CRMT cash_flow (quarterly, 2025-01-31) — Changes In Cash: -3326000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Common Stock: 156000.00
CRMT cash_flow (quarterly, 2025-01-31) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 557811000.00
CRMT cash_flow (quarterly, 2025-01-31) — Common Stock Issuance: 72000.00
CRMT cash_flow (quarterly, 2025-01-31) — Common Stock Payments: -20000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Construction In Progress: 4524000.00
CRMT income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 169374000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 11268000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Assets: 1423559000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Debt: 74000000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 74000000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 107501000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 107501000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 226042000.00
CRMT cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: -2851000.00
CRMT cash_flow (quarterly, 2025-01-31) — Deferred Tax: -2851000.00
CRMT cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 1890000.00
CRMT income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 1890000.00
CRMT cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 1890000.00
CRMT income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 1890000.00
CRMT income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 8413088.00
CRMT income_statement (quarterly, 2025-01-31) — Diluted EPS: 0.37
CRMT income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: 3152000.00
CRMT income_statement (quarterly, 2025-01-31) — EBIT: 21313000.00
CRMT income_statement (quarterly, 2025-01-31) — EBITDA: 23203000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Employee Benefits: 13148000.00
CRMT cash_flow (quarterly, 2025-01-31) — End Cash Position: 126358000.00
CRMT cash_flow (quarterly, 2025-01-31) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 28201000.00
CRMT cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -31527000.00
CRMT cash_flow (quarterly, 2025-01-31) — Gain Loss On Sale Of PPE: 0.00
CRMT income_statement (quarterly, 2025-01-31) — Gain On Sale Of Ppe: -37000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Goodwill: 22822000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Goodwill And Other Intangible Assets: 22822000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Gross Accounts Receivable: 1478905000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Gross PPE: 177907000.00
CRMT income_statement (quarterly, 2025-01-31) — Gross Profit: 156352000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Income Tax Payable: 526000.00
CRMT income_statement (quarterly, 2025-01-31) — Interest Expense: 16923000.00
CRMT income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 16923000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Interest Payable: 1703000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Inventory: 143933000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Invested Capital: 1354056000.00
CRMT cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -751000.00
CRMT cash_flow (quarterly, 2025-01-31) — Issuance Of Capital Stock: 72000.00
CRMT cash_flow (quarterly, 2025-01-31) — Issuance Of Debt: 363331000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Land And Improvements: 11998000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Leases: 51187000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Line Of Credit: 74000000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Loans Receivable: 645000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 67667000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Long Term Debt: 722245000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 789912000.00
CRMT cash_flow (quarterly, 2025-01-31) — Long Term Debt Issuance: -96424000.00
CRMT cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: 255847000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 22235000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Minority Interest: 100000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: 52000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Net Debt: 787713000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income: 3162000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 3152000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 3162000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 3162000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 3162000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 3162000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 3162000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Interest Income: -16923000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: 30655000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: 159423000.00
CRMT income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -16923000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: -2496000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Net PPE: 122527000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -751000.00
CRMT cash_flow (quarterly, 2025-01-31) — Net Short Term Debt Issuance: -128768000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 535389000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 19686000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Liabilities: 19686000.00
CRMT income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 23240000.00
CRMT income_statement (quarterly, 2025-01-31) — Normalized Income: 3188650.11
CRMT cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -30776000.00
CRMT cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 0.00
CRMT income_statement (quarterly, 2025-01-31) — Operating Income: 21350000.00
CRMT income_statement (quarterly, 2025-01-31) — Operating Revenue: 325726000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 8256765.00
CRMT income_statement (quarterly, 2025-01-31) — Other Income Expense: -37000.00
CRMT cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 9637000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 38191000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Other Properties: 64475000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Payables: 33273000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 44541000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Preferred Stock: 400000.00
CRMT income_statement (quarterly, 2025-01-31) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Preferred Stock Equity: 400000.00
CRMT income_statement (quarterly, 2025-01-31) — Pretax Income: 4390000.00
CRMT cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 0.00
CRMT balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
CRMT income_statement (quarterly, 2025-01-31) — Provision For Doubtful Accounts: 86652000.00
CRMT cash_flow (quarterly, 2025-01-31) — Provisionand Write Offof Assets: 86652000.00
CRMT cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -751000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Receivables: 1153268000.00
CRMT income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 169374000.00
CRMT income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 1890000.00
CRMT cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -330602000.00
CRMT cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -20000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Restricted Cash: 117826000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 661636000.00
CRMT cash_flow (quarterly, 2025-01-31) — Sale Of PPE: 0.00
CRMT income_statement (quarterly, 2025-01-31) — Selling General And Administration: 46460000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Share Issued: 15599303.00
CRMT cash_flow (quarterly, 2025-01-31) — Short Term Debt Issuance: 161257000.00
CRMT cash_flow (quarterly, 2025-01-31) — Short Term Debt Payments: -196898000.00
CRMT income_statement (quarterly, 2025-01-31) — Special Income Charges: -37000.00
CRMT cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: -1458000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 558211000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 534989000.00
CRMT income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -10349.89
CRMT income_statement (quarterly, 2025-01-31) — Tax Provision: 1228000.00
CRMT income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.28
CRMT balance_sheet (quarterly, 2025-01-31) — Taxes Receivable: 0.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Assets: 1607099000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 1280456000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Debt: 863912000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 558311000.00
CRMT income_statement (quarterly, 2025-01-31) — Total Expenses: 304376000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 1048788000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 183540000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 822746000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 526000.00
CRMT income_statement (quarterly, 2025-01-31) — Total Unusual Items: -37000.00
CRMT income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -37000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Treasury Shares Number: 7342538.00
CRMT balance_sheet (quarterly, 2025-01-31) — Treasury Stock: 298218000.00
CRMT balance_sheet (quarterly, 2025-01-31) — Working Capital: 1197517000.00
CRMT income_statement (annual, 2025-04-30) — +Operating Expense: 571127000.00
CRMT income_statement (quarterly, 2025-04-30) — +Operating Expense: 143252000.00
CRMT income_statement (annual, 2025-04-30) — +Total Revenue: 1390932000.00
CRMT income_statement (quarterly, 2025-04-30) — +Total Revenue: 370174000.00
CRMT balance_sheet (annual, 2025-04-30) — Accounts Payable: 34980000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 34980000.00
CRMT balance_sheet (annual, 2025-04-30) — Accounts Receivable: 1180010000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 1180010000.00
CRMT balance_sheet (annual, 2025-04-30) — Accrued Interest Receivable: 7432000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Accrued Interest Receivable: 7432000.00
CRMT balance_sheet (annual, 2025-04-30) — Accumulated Depreciation: -57312000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -57312000.00
CRMT balance_sheet (annual, 2025-04-30) — Additional Paid In Capital: 195225000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 195225000.00
CRMT balance_sheet (annual, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -323100000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -323100000.00
CRMT cash_flow (annual, 2025-04-30) — Asset Impairment Charge: 140000.00
CRMT cash_flow (quarterly, 2025-04-30) — Asset Impairment Charge: 20000.00
CRMT income_statement (annual, 2025-04-30) — Basic Average Shares: 7524770.00
CRMT income_statement (quarterly, 2025-04-30) — Basic Average Shares: 8260468.00
CRMT income_statement (annual, 2025-04-30) — Basic EPS: 2.38
CRMT income_statement (quarterly, 2025-04-30) — Basic EPS: 1.29